Randolph E. Regal

1.1k total citations
32 papers, 751 citations indexed

About

Randolph E. Regal is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Randolph E. Regal has authored 32 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in Randolph E. Regal's work include Liver Disease and Transplantation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Microscopic Colitis (4 papers). Randolph E. Regal is often cited by papers focused on Liver Disease and Transplantation (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Microscopic Colitis (4 papers). Randolph E. Regal collaborates with scholars based in United States, Canada and Ukraine. Randolph E. Regal's co-authors include Cesar Alaniz, Daryl D. DePestel, Rima A. Mohammad, William A. Prescott, Jeffrey J. Ellis, Michael A. Smith, Nghi B. Ha, Michael P. Dorsch, John I. Allen and Peter Higgins and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Critical Care Medicine.

In The Last Decade

Randolph E. Regal

30 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randolph E. Regal United States 14 254 193 141 138 107 32 751
Catherine Litalien Canada 18 270 1.1× 235 1.2× 68 0.5× 28 0.2× 153 1.4× 59 1.3k
Sheila M. Wilhelm United States 17 141 0.6× 295 1.5× 89 0.6× 31 0.2× 67 0.6× 44 898
I‐Jung Tsai Taiwan 20 199 0.8× 183 0.9× 40 0.3× 53 0.4× 158 1.5× 78 1.3k
J. F. T. Glasgow United Kingdom 21 215 0.8× 191 1.0× 83 0.6× 40 0.3× 57 0.5× 62 1.1k
Vijay Gayam United States 16 301 1.2× 336 1.7× 45 0.3× 124 0.9× 32 0.3× 127 1.3k
Abdel‐Naser Elzouki Qatar 16 278 1.1× 167 0.9× 57 0.4× 114 0.8× 14 0.1× 120 933
Umair Iqbal United States 19 441 1.7× 432 2.2× 31 0.2× 200 1.4× 54 0.5× 86 1.2k
Valentina Perrone Italy 19 177 0.7× 154 0.8× 66 0.5× 32 0.2× 62 0.6× 128 1.1k
Cesar Alaniz United States 13 173 0.7× 152 0.8× 43 0.3× 78 0.6× 23 0.2× 37 585
David D.K. Rolston United States 18 768 3.0× 520 2.7× 83 0.6× 108 0.8× 39 0.4× 38 1.6k

Countries citing papers authored by Randolph E. Regal

Since Specialization
Citations

This map shows the geographic impact of Randolph E. Regal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randolph E. Regal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randolph E. Regal more than expected).

Fields of papers citing papers by Randolph E. Regal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randolph E. Regal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randolph E. Regal. The network helps show where Randolph E. Regal may publish in the future.

Co-authorship network of co-authors of Randolph E. Regal

This figure shows the co-authorship network connecting the top 25 collaborators of Randolph E. Regal. A scholar is included among the top collaborators of Randolph E. Regal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randolph E. Regal. Randolph E. Regal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Berinstein, Jeffrey, Abhishek Satishchandran, Shirley Cohen‐Mekelburg, et al.. (2023). Tu1769 OFF-LABEL, HIGH-INTENSITY UPADACITINIB FOR HOSPITALIZED PATIENTS WITH SEVERE INFLAMMATORY BOWEL DISEASE. Gastroenterology. 164(6). S–1118. 2 indexed citations
3.
Berinstein, Jeffrey, Elliot Berinstein, Calen A. Steiner, et al.. (2021). Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study. Clinical Gastroenterology and Hepatology. 19(10). 2112–2120.e1. 75 indexed citations
4.
Mills, John, Christopher Zimmerman, Tejal Gandhi, et al.. (2020). Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces Clostridioides difficile and gastrointestinal panel testing. Infection Control and Hospital Epidemiology. 41(10). 1136–1141. 9 indexed citations
5.
Regal, Randolph E., et al.. (2019). Cirrhosis, Thrombosis, Finding FaXts about Doses: Dosing of Unfractionated Heparin for Venous Thromboembolism in Cirrhosis. Annals of Pharmacotherapy. 54(5). 450–456. 1 indexed citations
6.
Berinstein, Jeffrey, Calen A. Steiner, Randolph E. Regal, et al.. (2018). Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 17(5). 988–990.e1. 68 indexed citations
7.
Regal, Randolph E., et al.. (2017). Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis. World Journal of Hepatology. 9(3). 131–131. 13 indexed citations
8.
Ha, Nghi B. & Randolph E. Regal. (2016). Anticoagulation in Patients With Cirrhosis. Annals of Pharmacotherapy. 50(5). 402–409. 29 indexed citations
9.
Fries, Brant E., et al.. (2016). Do SSRI Antidepressants Increase The Risk of Extrapyramidal Side Effects In Patients Taking Antipsychotics?. PubMed. 41(2). 115–9. 5 indexed citations
10.
Mohammad, Rima A., Randolph E. Regal, & Cesar Alaniz. (2012). Combination Therapy for the Treatment and Prevention of Hepatic Encephalopathy. Annals of Pharmacotherapy. 46(11). 1559–1563. 22 indexed citations
11.
Harrison, Michelle, Jenny Leung, Karen Shen, Randolph E. Regal, & Cesar Alaniz. (2012). 964. Critical Care Medicine. 40. 1–328.
12.
Regal, Randolph E., et al.. (2008). Indications for Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Evidence-Based Recommendations for Use. Annals of Pharmacotherapy. 42(4). 550–557. 44 indexed citations
13.
Regal, Randolph E., et al.. (2006). Urinary Tract Infections in Extended Care Facilities: Preventive Management Strategies. The Consultant Pharmacist. 21(5). 400–409. 10 indexed citations
14.
Regal, Randolph E., et al.. (2006). Acid Suppressive Therapy Use on an Inpatient Internal Medicine Service. Annals of Pharmacotherapy. 40(7-8). 1261–1266. 115 indexed citations
15.
Walker, Paul C., et al.. (2005). Medication use as a risk factor for falls among hospitalized elderly patients. American Journal of Health-System Pharmacy. 62(23). 2495–2499. 47 indexed citations
16.
Regal, Randolph E., et al.. (2004). Optimal understanding of warfarin: Beyond the nomogram. 29(10). 652–656. 1 indexed citations
17.
Prescott, William A., Daryl D. DePestel, Jeffrey J. Ellis, & Randolph E. Regal. (2004). Incidence of Carbapenem‐Associated Allergic‐Type Reactions among Patients with versus Patients without a Reported Penicillin Allergy. Clinical Infectious Diseases. 38(8). 1102–1107. 67 indexed citations
18.
Regal, Randolph E., et al.. (2004). Drug Interactions Between Antibiotics and Select Maintenance Medications: Seeing More Clearly Through the Narrow Therapeutic Window of Opportunity. The Consultant Pharmacist. 19(12). 1119–1128. 2 indexed citations
19.
Regal, Randolph E., Daryl D. DePestel, & Heather L. VandenBussche. (2003). The Effect of an Antimicrobial Restriction Program on Pseudomonas aeruginosa Resistance to β‐Lactams in a Large Teaching Hospital. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(5). 618–624. 29 indexed citations
20.
Simon, Laura, et al.. (1970). [Muscular manifestations of human cysticercosis].. PubMed. 22(9). 357–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Litalien Breakdown of academic impact, for papers by Sheila M. Wilhelm Breakdown of academic impact, for papers by I‐Jung Tsai Breakdown of academic impact, for papers by J. F. T. Glasgow Breakdown of academic impact, for papers by Vijay Gayam Breakdown of academic impact, for papers by Abdel‐Naser Elzouki Breakdown of academic impact, for papers by Umair Iqbal Breakdown of academic impact, for papers by Valentina Perrone Breakdown of academic impact, for papers by Cesar Alaniz Breakdown of academic impact, for papers by David D.K. Rolston
Rankless by CCL
2026